Latest Trials

EudraCT Number: 2004-002854-78 Sponsor Protocol Number: BO17706 Start Date: 2005-05-23
Sponsor Name: F. Hoffmann-La Roche Ltd.
Full Title: A randomised, double blind, placebo controlled, multicentre phase III trial to evaluate the efficacy and safety of adding bevacizumab to gemcitabine and erlotinib in patients with metastatic pancre...
Medical condition: Metastatic pancreatic cancer (adenocarcinoma)
Disease: Version SOC Term Classification Code Term Level
PT 10033610 7.1
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed) DE (Completed) FI (Completed) GB (Completed) SE (Completed) CZ (Completed) ES (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2004-004124-12 Sponsor Protocol Number: 55730 Start Date: 2005-05-23
Sponsor Name: AZIENDA SANITARIA OSPEDALIERA O.I.R.M. - S. ANNA
Full Title: LACTOBACILLUS REUTERI REUTERIN AS A THERAPEUTIC AGENT IN INFANTILE COLIC A PROSPECTIVE STUDY.
Medical condition: TREATMENT OF INFANTILE COLIC IN BREASTFED INFANTS OF AGE BETWEEN 21 AND 90 DAYS
Disease: Version SOC Term Classification Code Term Level
6.1 10017947 SOC
Population Age: Infants and toddlers, Under 18 Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)
EudraCT Number: 2005-001041-42 Sponsor Protocol Number: VAC030 Start Date: 2005-05-23
Sponsor Name: University of Oxford
Full Title: Assessment of protection against malaria by sporozoite challenge of healthy adults vaccinated with the virosomal vaccine PEV3A and FP9-MVA ME-TRAP
Medical condition: Plasmodium falciparum malaria
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2004-004384-29 Sponsor Protocol Number: Levosepsis1 Start Date: 2005-05-23
Sponsor Name: Dr GED DEMPSEY, University Hospital Aintree
Full Title: Double blind randomised controlled trial of Levosimendan versus Dopexamine in septic shock
Medical condition: Septic Shock
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: (No results available)
EudraCT Number: 2004-003985-14 Sponsor Protocol Number: CPR-EFC5816-EN-E01 Start Date: 2005-05-23
Sponsor Name: Sanofi-Synthelabo Research
Full Title: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Effect of Two Doses of a Vasopressin V2 Receptor Antagonist (SR121463B) on Serum Sodium in Patients with Dilutional ...
Medical condition: Dilutional hyponatremia excluding chronic syndrome of inappropriate antidiuretic hormone secretion (SIADH) or cirrhosis
Disease: Version SOC Term Classification Code Term Level
7.1 10021038 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) BE (Completed) SE (Completed) DK (Completed)
Trial results: View results
EudraCT Number: 2005-001507-19 Sponsor Protocol Number: 04/5/025 Start Date: 2005-05-22
Sponsor Name: National Children's Hospital & Trinity College Dublin
Full Title: Treatment with recombinant Growth Hormone in Children born Small for Gestational Age (SGA) without Catch-up Growth.
Medical condition: Short stature in children born small for gestational age without catch up growth
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: IE (Completed)
Trial results: (No results available)
EudraCT Number: 2004-004512-23 Sponsor Protocol Number: PKU-003 Start Date: 2005-05-22
Sponsor Name: BioMarin Pharmaceutical Inc.
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Phenoptin in Subjects with Phenylketonuria Who Have Elevated Phenylalanine Levels
Medical condition: Phenylketonuria (PKU)
Disease: Version SOC Term Classification Code Term Level
6.1 10034872
Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: IE (Completed) GB (Completed) DE (Completed) IT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-004924-11 Sponsor Protocol Number: SHX0712 Start Date: 2005-05-20
Sponsor Name: ALK-Abelló A/S
Full Title: A multicentre, randomised, double-blind, placebo-controlled parallel group clinical trial to investigate the efficacy and safety of specific sublingual immunotherapy with SLIT One birch in patients...
Medical condition: Desensibilisierung gegenüber Allergenen
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2005-001094-95 Sponsor Protocol Number: IP-MEL-SOYWB-05037 Start Date: 2005-05-20
Sponsor Name: MELORA PORTUGUESA. LDA.
Full Title: ESTUDIO DE LOS BENEFICIOS DE LAS ISOFLAVONAS DE SOJA, GENISTEÍNA, DAIDZEÍNA Y GLICITEÍNA EN LA MUJER POSTMENOPÁUSICA
Medical condition: POSMENOPAUSAL WOMEN
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-000370-31 Sponsor Protocol Number: NKT102260 Start Date: 2005-05-20
Sponsor Name: GlaxoSmithKline Group of Companies
Full Title: A Multicentre, Randomised, Double-blind, Placebo-controlled, Dose-ranging, Parallel Group Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of the Oral Neurokinin-1 Receptor Ant...
Medical condition: Post Operative Nausea and Vomiting (PONV) Post Discharge Nausea and Vomiting (PDNV)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Female
Trial protocol: HU (Completed) BE (Completed) DE (Completed) ES (Completed)
Trial results: View results

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe